ribavirin has been researched along with Anxiety in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukui, N; Kamimura, K; Kawai, H; Mizuno, K; Sakai, N; Sakamaki, A; Someya, T; Sugai, T; Takamura, M; Terai, S; Tominaga, K; Watanabe, H; Yamagiwa, S | 1 |
| Ahmed, GK; Darwish, AM; Hassaan, SH; Hassany, SM; Khalifa, H; Moustafa, EF; Ramadan, HKA | 1 |
| Capuron, L; de la Torre, R; Giménez, D; Gratacòs, M; Langohr, K; Martín-Santos, R; Moreno-España, J; Navinés, R; Solà, R; Udina, M | 1 |
| Anderson, RT; Baran, RW; Dietz, B; Erickson, P; Gooch, K; Revicki, DA | 1 |
| Bertino, G; Caraci, F; Chisari, G; Drago, F; Greco, C; Malaguarnera, G; Malaguarnera, M; Motta, M; Nunnari, G; Vacante, M; Vecchio, M | 1 |
| Chang, JJ; Chen, CK; Chen, LW; Chen, SW; Chien, RN; Lee, TS; Liu, CJ; Wang, LJ; Yen, CL | 1 |
| Carral Martínez, M; García-Toro, M; Gili Planas, M; Jimeno Beltrán, T; Pradas Guerrero, C; Roca Bennasar, M; Román Ruiz del Moral, Y; Vilella Martorell, A | 1 |
| Beem, LW; Morse, ML | 1 |
| Barry, K; Cleare, AJ; Hotopf, M; Landau, S; Maddock, C; Maulayah, P; Norris, S; Pariante, CM | 1 |
| Fontana, RJ | 1 |
1 review(s) available for ribavirin and Anxiety
| Article | Year |
|---|---|
Neuropsychiatric toxicity of antiviral treatment in chronic hepatitis C.
Topics: Antiviral Agents; Anxiety; Chronic Disease; Cognition; Depression; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Ribavirin; Sleep Initiation and Maintenance Disorders | 2000 |
4 trial(s) available for ribavirin and Anxiety
| Article | Year |
|---|---|
Psychometric evaluation of the hepatitis C virus patient-reported outcomes (HCV-PRO) instrument: validity, responsiveness, and identification of the minimally important difference in a phase 2 clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Anxiety; Data Interpretation, Statistical; Depression; Drug Therapy, Combination; Female; Health Status Indicators; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon Type I; Male; Middle Aged; Patient Outcome Assessment; Placebos; Psychometrics; Quality of Life; Reproducibility of Results; Ribavirin; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2014 |
Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability.
Topics: Adult; Antioxidants; Antiviral Agents; Anxiety; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Psychiatric Status Rating Scales; Ribavirin; Silybin; Silymarin; Treatment Outcome; Work Performance | 2016 |
Treatment-emergent depression and anxiety between peginterferon alpha-2a versus alpha-2b plus ribavirin for chronic hepatitis C.
Topics: Antiviral Agents; Anxiety; China; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin | 2016 |
Psychopathological symptoms during interferon-alpha and ribavirin treatment: effects on virologic response.
Topics: Adult; Antiviral Agents; Anxiety; Depression; Drug Carriers; Drug Therapy, Combination; Fatigue; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Severity of Illness Index; Substance-Related Disorders; Time Factors; Treatment Outcome | 2005 |
5 other study(ies) available for ribavirin and Anxiety
| Article | Year |
|---|---|
A case report of psychiatric symptoms following direct-acting antiviral and ribavirin combination therapy for chronic hepatitis C in a patient with innate anxiety.
Topics: Antiviral Agents; Anxiety; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Middle Aged; Ribavirin | 2019 |
Assessment of cognitive functions and psychiatric symptoms in hepatitis C patients receiving pegylated interferon alpha and ribavirin: A prospective cohort study.
Topics: Adult; Antiviral Agents; Anxiety; Cognition; Depression; Female; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Neuropsychological Tests; Polyethylene Glycols; Prospective Studies; Ribavirin | 2019 |
Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents; Antiviral Agents; Anxiety; Cohort Studies; Depression; Drug Therapy, Combination; Fatigue; Genetic Predisposition to Disease; Hepatitis C, Chronic; Humans; INDEL Mutation; Interferon-alpha; Interleukin-6; Middle Aged; Point Mutation; Polyethylene Glycols; Promoter Regions, Genetic; Prospective Studies; Recombinant Proteins; Ribavirin; Serotonin; Serotonin Plasma Membrane Transport Proteins; White People | 2013 |
[Use of anxiolytics and antidepressants before and after treatment with interferon-alpha and ribavirin in patients with hepatitis C].
Topics: Anti-Anxiety Agents; Antidepressive Agents; Antiviral Agents; Anxiety; Depression; Drug Therapy, Combination; Hepatitis C; Humans; Incidence; Interferon-alpha; Retrospective Studies; Ribavirin | 2011 |
Benefits of Reiki therapy for a severely neutropenic patient with associated influences on a true random number generator.
Topics: Anxiety; Consciousness; Hematocrit; Hepacivirus; Hepatitis C; Humans; Interferons; Leukocyte Count; Male; Middle Aged; Mind-Body Relations, Metaphysical; Neutropenia; Neutrophils; Ribavirin; Severity of Illness Index; Spirituality; Therapeutic Touch | 2011 |